Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial (Q35886534)
Jump to navigation
Jump to search
scientific article published in January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial |
scientific article published in January 2014 |
Statements
1 reference
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial (English)
1 reference
Mark H Einstein
Peter Takacs
Archana Chatterjee
Rhoda S Sperling
Nahida Chakhtoura
Mark M Blatter
Jacob Lalezari
Marie-Pierre David
Lan Lin
Gary Dubin
HPV-010 Study Group